Introduction and Objective: Rho-kinase (ROCK) isoforms, ROCK1 and ROCK2, have been implicated in regulating glucose metabolism, insulin signaling, and energy balance. However, the isoform-specific role of ROCK2 in adipose tissue remains elusive. This study investigated the effects of adipose-specific ROCK2 deletion on insulin signaling, energy metabolism, and obesity development using adiponectin-Cre; ROCK2loxP/loxP mice (A-ROCK2-/-). Methods: Under a normal chow diet, A-ROCK2-/- mice maintained normal body weight, glucose homeostasis, and thermogenic responses. However, when challenged with a high-fat diet, A-ROCK2-/- mice showed increased weight gain and adiposity, accompanied by hyperinsulinemia, hyperleptinemia, and impaired insulin sensitivity. Results: These effects occurred without changes in energy expenditure or locomotor activity. Thermogenic gene expression in brown fat was not changed, but was significantly reduced in inguinal white fat. Furthermore, hypothalamic expression of orexigenic neuropeptides and TGF-β was modestly elevated. Importantly, adipose-specific ROCK2 deletion markedly reduced insulin-stimulated phosphorylation of insulin receptor, Akt, and AS160 in adipose tissue but not the liver or muscle. In vitro studies showed that ROCK2 physically binds to the insulin receptor and directly phosphorylates it at residues T1058, S1064, and T1172, identifying the insulin receptor as a new substrate for ROCK2. The function of these specific phosphorylation sites on insulin signaling is currently under investigation. These adipose-specific effects contrast with the results from systemic ROCK2 deletion, which has been shown to enhance energy expenditure and insulin sensitivity, highlighting the importance of tissue context. Conclusion: Our findings demonstrate that adipose ROCK2 plays a pivotal role in regulating insulin sensitivity and adiposity, particularly under conditions of overnutrition. Disclosure K. Rodrigues: None. M. Kang: None. W. Yang: None. D. Lim: None. M. Shibata: None. M. Lee: None. J. Young: None. S. Kim: None. C.S. Ryu: None. S. Han: None. A.A. Uner: None. Y. Kim: None. Funding American Diabetes Association (1-25-PDF-49), National Institutes of Health (R01 DK129946)
RODRIGUES et al. (Fri,) studied this question.